CompletedNot Applicable

Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients

Switzerland1,353 participantsStarted 2020-06-22

Plain-language summary

Hospital-acquired venous thromboembolism (HA-VTE) is one of the leading preventable causes of in-hospital mortality, but prevention of VTE in hospitalized medical patients remains challenging, as preventive measures such as pharmacological thromboprophylaxis (TPX) need to be tailored to individual thrombotic risk. The broad objective of this project is to improve VTE prevention strategies in hospitalized medical patients by prospectively examining VTE risk factors (including mobility) and comparing existing risk assessment models.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥18 years * Admitted for hospitalization \>24 hours on a general internal medicine ward * Informed consent as documented by signature Exclusion Criteria: * Need for therapeutic anticoagulation (e.g., atrial fibrillation) * Life expectancy \<30 days * Insufficient proficiency of the German or French language * Unwilling to provide informed consent * Prior enrolment in the study

What they're measuring

Venous thromboembolism

Timeframe: Within 90 days of initial hospital admission

Trial details

NCT IDNCT04439383

SponsorInsel Gruppe AG, University Hospital Bern

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-04-01

View on ClinicalTrials.gov More Venous Thromboembolism trials